ReviewFrontiers in pharmacology2024
Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.
Mohamed Tawengi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it